NASDAQ:CARA
Cara Therapeutics Stock News
$0.750
-0.0551 (-6.84%)
At Close: May 17, 2024
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
06:47pm, Monday, 10'th May 2021
Cara (CARA) delivered earnings and revenue surprises of 24.19% and -80.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics: Q1 Earnings Insights
04:49pm, Monday, 10'th May 2021
Shares of Cara Therapeutics (NASDAQ:CARA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 24.19% year over year to ($0.47), which bea
Cara Therapeutics Reports First Quarter 2021 Financial Results
04:01pm, Monday, 10'th May 2021
– U.S. Food and Drug Administration (FDA) Accepts New Drug Application (NDA) Filing and Grants Priority Review for KORSUVA™ Injection in CKD-aP –
Cara Therapeutics (CARA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
03:47pm, Monday, 03'rd May 2021
Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cara Therapeutics Stock Is Crashing Today
11:33am, Thursday, 29'th Apr 2021
The company reported disappointing results from a phase 2 study.
CARA Stock: From $25.79 To $15.64 Pre-Market Explanation
08:44am, Thursday, 29'th Apr 2021
The stock price of Cara Therapeutics Inc (NASDAQ: CARA) fell from $25.79 to $15.64 as of 8:38 AM ET. This is why it happened.
Cara Therapeutics: Upcoming PDUFA May See Some Upside
04:08pm, Sunday, 25'th Apr 2021
Cara Therapeutics: Upcoming PDUFA May See Some Upside
Cara Therapeutics to Present at the 20th Annual Needham Healthcare Conference
04:01pm, Wednesday, 07'th Apr 2021
STAMFORD, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
Cara (CARA) Surges 14%: Is This an Indication of Further Gains?
10:36am, Wednesday, 07'th Apr 2021
Cara (CARA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options
09:06am, Wednesday, 07'th Apr 2021
Investors need to pay close attention to Cara Therapeutics (CARA) stock based on the movements in the options market lately.
Why Cara Therapeutics Stock Is Soaring Higher Today
10:59am, Tuesday, 06'th Apr 2021
The biotech stock is being added to an important small-cap index.
Cara Therapeutics Stock Soars After S&P 600 Index Update
10:19am, Tuesday, 06'th Apr 2021
The shares of Cara Therapeutics Inc (NASDAQ:CARA) are up 13.1% to trade at $23.82 at last check -- their highest level in over a year -- on reports that the equity will be added to the S&P 600 Smal
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning
07:12am, Tuesday, 06'th Apr 2021
Investors getting ready for another busy day of trading need to make sure they know the biggest pre-market stock movers before markets open. The post Today's Biggest Pre-Market Stock Movers: 10 Top Ga
Cara Therapeutics Stock Price Increased Over 10% Pre-Market: Why It Happened
06:20am, Tuesday, 06'th Apr 2021
The stock price of Cara Therapeutics Inc. (NASDAQ: CARA) increased by over 10% pre-market. This is why it happened.
Cara Therapeutics to Host Virtual Research and Development Event on April 7, 2021
07:00am, Wednesday, 31'st Mar 2021
STAMFORD, Conn., March 31, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
